FROM THE NEWS FEED
In recent FDA Phase 2 trials, a single dose of the experimental psychedelic luvesilocin eliminated postpartum depression symptoms in 71% of patients within seven days. The breakthrough medication will enter Phase 3 trials by late 2026.
Continue to the original publication for the complete article.
KEEP EXPLORING
Ketamine and psychedelics relieve severe depression in hours, but their exact mechanisms remain elusive. New research...
Taking psychedelics on the Fourth of July is linked to decreased support for partisan violence, while using them duri...
In a small psilocybin trial for alcohol use disorder, people who stayed alcohol-free three months later tended to des...
Psychedelics are no magic wand or silver bullet. However, in partnership with talk therapy, physical therapy, and oth...
Hereβs what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
Hereβs what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
There are many factors that can affect your journey, from set and setting to substance and dosage. At Psychedelic Pas...
Personal growth is a lifelong process. We've heard from so many people that, after years of other avenues, a psychede...
Again and again, we find that psychedelics can be the missing element that help people to heal and recover from past ...